Asset Entities ASST Medical Device — Net loss
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Asset Entities in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Asset Entities’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Asset Entities's medical device — net loss.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Asset Entities's medical device — net loss?
- Asset Entities (ASST) reported medical device — net loss of -$5.91M in Q1 2026.
- What does medical device — net loss mean?
- This metric represents the net financial loss generated specifically by the medical device business segment after accounting for all associated operating expenses and costs. It serves as an indicator of the segment's current profitability challenges and the extent to which it requires capital support from the broader organization. Investors use this to evaluate the segment's burn rate and the efficiency of its cost structure relative to its revenue generation.